Cargando…
P1447: INFERIOR OUTCOMES OF EU VS. US PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA AFTER CD19 CAR T-CELL THERAPY ARE IMPACTED BY BASELINE RISK FACTORS AND CAR PRODUCT CHOICE
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430780/ http://dx.doi.org/10.1097/01.HS9.0000848644.19354.c7 |
| _version_ | 1784779870767677440 |
|---|---|
| author | Bücklein, V. Perez, A. Iacoboni, G. Rejeski, K. Holtick, U. Penack, O. Kharboutli, S. Blumenberg, V. Ackermann, J. Frölich, L. Johnson, G. Patel, K. Arciola, B. Schmidt, C. Albanyan, O. Gödel, P. Hoster, E. Bullinger, L. Mackensen, A. Locke, F. von Bergwelt, M. Barba, P. Jain, M. D. Subklewe, M. |
| author_facet | Bücklein, V. Perez, A. Iacoboni, G. Rejeski, K. Holtick, U. Penack, O. Kharboutli, S. Blumenberg, V. Ackermann, J. Frölich, L. Johnson, G. Patel, K. Arciola, B. Schmidt, C. Albanyan, O. Gödel, P. Hoster, E. Bullinger, L. Mackensen, A. Locke, F. von Bergwelt, M. Barba, P. Jain, M. D. Subklewe, M. |
| author_sort | Bücklein, V. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430780 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94307802022-08-31 P1447: INFERIOR OUTCOMES OF EU VS. US PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA AFTER CD19 CAR T-CELL THERAPY ARE IMPACTED BY BASELINE RISK FACTORS AND CAR PRODUCT CHOICE Bücklein, V. Perez, A. Iacoboni, G. Rejeski, K. Holtick, U. Penack, O. Kharboutli, S. Blumenberg, V. Ackermann, J. Frölich, L. Johnson, G. Patel, K. Arciola, B. Schmidt, C. Albanyan, O. Gödel, P. Hoster, E. Bullinger, L. Mackensen, A. Locke, F. von Bergwelt, M. Barba, P. Jain, M. D. Subklewe, M. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430780/ http://dx.doi.org/10.1097/01.HS9.0000848644.19354.c7 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Bücklein, V. Perez, A. Iacoboni, G. Rejeski, K. Holtick, U. Penack, O. Kharboutli, S. Blumenberg, V. Ackermann, J. Frölich, L. Johnson, G. Patel, K. Arciola, B. Schmidt, C. Albanyan, O. Gödel, P. Hoster, E. Bullinger, L. Mackensen, A. Locke, F. von Bergwelt, M. Barba, P. Jain, M. D. Subklewe, M. P1447: INFERIOR OUTCOMES OF EU VS. US PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA AFTER CD19 CAR T-CELL THERAPY ARE IMPACTED BY BASELINE RISK FACTORS AND CAR PRODUCT CHOICE |
| title | P1447: INFERIOR OUTCOMES OF EU VS. US PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA AFTER CD19 CAR T-CELL THERAPY ARE IMPACTED BY BASELINE RISK FACTORS AND CAR PRODUCT CHOICE |
| title_full | P1447: INFERIOR OUTCOMES OF EU VS. US PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA AFTER CD19 CAR T-CELL THERAPY ARE IMPACTED BY BASELINE RISK FACTORS AND CAR PRODUCT CHOICE |
| title_fullStr | P1447: INFERIOR OUTCOMES OF EU VS. US PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA AFTER CD19 CAR T-CELL THERAPY ARE IMPACTED BY BASELINE RISK FACTORS AND CAR PRODUCT CHOICE |
| title_full_unstemmed | P1447: INFERIOR OUTCOMES OF EU VS. US PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA AFTER CD19 CAR T-CELL THERAPY ARE IMPACTED BY BASELINE RISK FACTORS AND CAR PRODUCT CHOICE |
| title_short | P1447: INFERIOR OUTCOMES OF EU VS. US PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA AFTER CD19 CAR T-CELL THERAPY ARE IMPACTED BY BASELINE RISK FACTORS AND CAR PRODUCT CHOICE |
| title_sort | p1447: inferior outcomes of eu vs. us patients with relapsed/refractory large b-cell lymphoma after cd19 car t-cell therapy are impacted by baseline risk factors and car product choice |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430780/ http://dx.doi.org/10.1097/01.HS9.0000848644.19354.c7 |
| work_keys_str_mv | AT buckleinv p1447inferioroutcomesofeuvsuspatientswithrelapsedrefractorylargebcelllymphomaaftercd19cartcelltherapyareimpactedbybaselineriskfactorsandcarproductchoice AT pereza p1447inferioroutcomesofeuvsuspatientswithrelapsedrefractorylargebcelllymphomaaftercd19cartcelltherapyareimpactedbybaselineriskfactorsandcarproductchoice AT iacobonig p1447inferioroutcomesofeuvsuspatientswithrelapsedrefractorylargebcelllymphomaaftercd19cartcelltherapyareimpactedbybaselineriskfactorsandcarproductchoice AT rejeskik p1447inferioroutcomesofeuvsuspatientswithrelapsedrefractorylargebcelllymphomaaftercd19cartcelltherapyareimpactedbybaselineriskfactorsandcarproductchoice AT holticku p1447inferioroutcomesofeuvsuspatientswithrelapsedrefractorylargebcelllymphomaaftercd19cartcelltherapyareimpactedbybaselineriskfactorsandcarproductchoice AT penacko p1447inferioroutcomesofeuvsuspatientswithrelapsedrefractorylargebcelllymphomaaftercd19cartcelltherapyareimpactedbybaselineriskfactorsandcarproductchoice AT kharboutlis p1447inferioroutcomesofeuvsuspatientswithrelapsedrefractorylargebcelllymphomaaftercd19cartcelltherapyareimpactedbybaselineriskfactorsandcarproductchoice AT blumenbergv p1447inferioroutcomesofeuvsuspatientswithrelapsedrefractorylargebcelllymphomaaftercd19cartcelltherapyareimpactedbybaselineriskfactorsandcarproductchoice AT ackermannj p1447inferioroutcomesofeuvsuspatientswithrelapsedrefractorylargebcelllymphomaaftercd19cartcelltherapyareimpactedbybaselineriskfactorsandcarproductchoice AT frolichl p1447inferioroutcomesofeuvsuspatientswithrelapsedrefractorylargebcelllymphomaaftercd19cartcelltherapyareimpactedbybaselineriskfactorsandcarproductchoice AT johnsong p1447inferioroutcomesofeuvsuspatientswithrelapsedrefractorylargebcelllymphomaaftercd19cartcelltherapyareimpactedbybaselineriskfactorsandcarproductchoice AT patelk p1447inferioroutcomesofeuvsuspatientswithrelapsedrefractorylargebcelllymphomaaftercd19cartcelltherapyareimpactedbybaselineriskfactorsandcarproductchoice AT arciolab p1447inferioroutcomesofeuvsuspatientswithrelapsedrefractorylargebcelllymphomaaftercd19cartcelltherapyareimpactedbybaselineriskfactorsandcarproductchoice AT schmidtc p1447inferioroutcomesofeuvsuspatientswithrelapsedrefractorylargebcelllymphomaaftercd19cartcelltherapyareimpactedbybaselineriskfactorsandcarproductchoice AT albanyano p1447inferioroutcomesofeuvsuspatientswithrelapsedrefractorylargebcelllymphomaaftercd19cartcelltherapyareimpactedbybaselineriskfactorsandcarproductchoice AT godelp p1447inferioroutcomesofeuvsuspatientswithrelapsedrefractorylargebcelllymphomaaftercd19cartcelltherapyareimpactedbybaselineriskfactorsandcarproductchoice AT hostere p1447inferioroutcomesofeuvsuspatientswithrelapsedrefractorylargebcelllymphomaaftercd19cartcelltherapyareimpactedbybaselineriskfactorsandcarproductchoice AT bullingerl p1447inferioroutcomesofeuvsuspatientswithrelapsedrefractorylargebcelllymphomaaftercd19cartcelltherapyareimpactedbybaselineriskfactorsandcarproductchoice AT mackensena p1447inferioroutcomesofeuvsuspatientswithrelapsedrefractorylargebcelllymphomaaftercd19cartcelltherapyareimpactedbybaselineriskfactorsandcarproductchoice AT lockef p1447inferioroutcomesofeuvsuspatientswithrelapsedrefractorylargebcelllymphomaaftercd19cartcelltherapyareimpactedbybaselineriskfactorsandcarproductchoice AT vonbergweltm p1447inferioroutcomesofeuvsuspatientswithrelapsedrefractorylargebcelllymphomaaftercd19cartcelltherapyareimpactedbybaselineriskfactorsandcarproductchoice AT barbap p1447inferioroutcomesofeuvsuspatientswithrelapsedrefractorylargebcelllymphomaaftercd19cartcelltherapyareimpactedbybaselineriskfactorsandcarproductchoice AT jainmd p1447inferioroutcomesofeuvsuspatientswithrelapsedrefractorylargebcelllymphomaaftercd19cartcelltherapyareimpactedbybaselineriskfactorsandcarproductchoice AT subklewem p1447inferioroutcomesofeuvsuspatientswithrelapsedrefractorylargebcelllymphomaaftercd19cartcelltherapyareimpactedbybaselineriskfactorsandcarproductchoice |